(Q47294866)

13 January 2018

title

Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer (English)

1 reference

13 January 2018

8

Jürgen Debus

1 reference

13 January 2018

Anna Nikoghosyan

1

1 reference

13 January 2018

Daniela Schulz-Ertner

2

1 reference

13 January 2018

Bernd Didinger

3

1 reference

13 January 2018

Oliver Jäkel

4

1 reference

13 January 2018

Ivan Zuna

5

1 reference

13 January 2018

Angelika Höss

6

1 reference

13 January 2018

Michael Wannenmacher

7

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 January 2004

1 reference

13 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 January 2018

volume

58

1 reference

13 January 2018

issue

1

1 reference

13 January 2018

page(s)

89-97

1 reference

13 January 2018

Particle beam therapy (hadrontherapy): basis for interest and clinical experience

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Development of fast neutron therapy worldwide. Radiobiological, clinical and technical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Fast neutron irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Prostate target volume variations during a course of radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Analysis of prostate and seminal vesicle motion: implications for treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Prostate motion during standard radiotherapy as assessed by fiducial markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

[First experiences with a noninvasive patient set-up system for radiotherapy of the prostate]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Stereotactically guided fractionated radiotherapy: technical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Neutron radiation and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Cell kinetic measurements in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Measurements and clinical consequences of prostate motion during a radiotherapy fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Organ motion and its management

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

The use of adaptive radiation therapy to reduce setup error: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Conformal proton therapy for early-stage prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901439-1

7 January 2021

10.1016/S0360-3016(03)01439-1

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018